Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma

Leukemia. 2007 Oct;21(10):2227-30. doi: 10.1038/sj.leu.2404780. Epub 2007 Jun 7.

Authors

D H Kim, J H Baek, Y S Chae, Y-K Kim, H J Kim, Y H Park, H S Song, J S Chung, M S Hyun, S K Sohn

PMID: 17554383
DOI: 10.1038/sj.leu.2404780

No abstract available

Publication types

Letter

MeSH terms

Antigens, CD20 / biosynthesis
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Cyclophosphamide / administration & dosage
Doxorubicin / administration & dosage
Humans
Lymphocyte Count
Lymphocytes / cytology*
Lymphoma, B-Cell / drug therapy*
Lymphoma, B-Cell / mortality
Lymphoma, B-Cell / pathology*
Lymphoma, Large B-Cell, Diffuse / drug therapy*
Lymphoma, Large B-Cell, Diffuse / mortality
Lymphoma, Large B-Cell, Diffuse / pathology*
Medical Oncology / methods
Multivariate Analysis
Odds Ratio
Prednisolone / administration & dosage
Prognosis
Time Factors
Treatment Outcome
Vincristine / administration & dosage

Substances

Antigens, CD20
Vincristine
Doxorubicin
Cyclophosphamide
Prednisolone

Supplementary concepts

VAP-cyclo protocol